ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,821.80
0.68%
S&P ASX All Technology
3,088.00
0.64%
Brent Oil
78.435
-0.16%
US Dollar vs AUD
1.50469
0.15%
Bitcoin
70,928.03
-0.21%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Daiichi Sankyo Company Ltd (PK) (DSNKY)

  7. Daiichi Sankyo Company Ltd (PK) (DSNKY) News

DSNKY

Daiichi Sankyo (PK) (DSNKY)

Daiichi Sankyo Company Ltd (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:DSNKY
DateTimeSourceHeadlineSymbolCompany
23/10/202317:49Dow Jones NewsAstraZeneca, Daiichi Sankyo's Enhertu Gets Approval in EU For Lung Cancer TreatmentUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
20/10/202311:30Dow Jones NewsMerck, Daiichi Sankyo Ink Commercialization Deal for Up to $22 BillionUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
22/09/202316:53Dow Jones NewsAstraZeneca Says Trial Results For Breast Cancer Drug Were Highly PositiveUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
16/09/202300:51Dow Jones NewsAstraZeneca's Lung-Cancer Treatment Gets Recommended for Approval in the EUUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
11/09/202316:55Dow Jones NewsAstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control RatesUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
03/07/202316:50Dow Jones NewsAstraZeneca Says Datopotamab Deruxtecan Phase 3 Trial Shows Positive Results in Lung Cancer PatientsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
05/06/202322:53Dow Jones NewsAstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful, Durable Response in TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
14/11/202218:52Dow Jones NewsAstraZeneca Says Enhertu Recommended for EU Approval for Gastric CancerUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
12/08/202216:53Dow Jones NewsAstraZeneca, Daiichi's Enhertu Approved by the FDA for Lung Cancer TreatmentUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
09/08/202220:49Dow Jones NewsAstraZeneca Reports Promising Data From Lung Cancer TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
27/06/202216:55Dow Jones NewsAstraZeneca Enhertu Breast Cancer Drug Is Recommended for EU ApprovalUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
05/05/202217:03Dow Jones NewsAstraZeneca's Enhertu Approved in US for Metastatic Breast Cancer TreatmentUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
19/04/202216:55Dow Jones NewsAstraZeneca, Daiichi Sankyo Say FDA Has Accepted Enhertu for Priority ReviewUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
21/02/202220:38Dow Jones NewsAstraZeneca, Daiichi Sankyo Report Positive Trial Results for Enhertu Breast-Cancer Treatment -- UpdateUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/01/202218:54Dow Jones NewsAstraZeneca's Enhertu Granted Priority Review by US RegulatorUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
18/09/202103:05Dow Jones NewsAstraZeneca Sees Positive Results for Enhertu TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
30/03/201918:02Dow Jones NewsCancer Drug Deal Carries High Price -- WSJUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
28/07/201622:10Dow Jones NewsChina's Fosun Close to Deal for India's Gland PharmaUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
21/04/201508:00Dow Jones NewsDaiichi Sankyo to Sell Sun Pharma StakeUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
24/03/201508:44The Motley FoolThis Market Could Grow 6250% in 10 YearsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
24/03/201501:14The Motley FoolThis Market Could Grow 6250% in 10 YearsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
03/12/201407:38Dow Jones NewsAbilify Maker Otsuka to Buy Avanir for $3.5 BillionUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
24/01/201412:12Dow Jones NewsFDA Bars Ingredients From Ranbaxy's India PlantUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/09/201320:43Dow Jones NewsASIA MARKETS: China Leads Asia Stocks LowerUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/09/201316:03Dow Jones NewsASIA MARKETS: Asia Stocks Mostly Lower Ahead Of Fed MeetingUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/09/201314:08Dow Jones NewsASIA MARKETS: Asia Stocks Mostly Lower Ahead Of Fed MeetingUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/09/201312:06Dow Jones NewsASIA MARKETS: Asia Stocks Mostly Lower Ahead Of Fed MeetingUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
02/09/201318:35Dow Jones NewsASIA MARKETS: Hong Kong Stocks Jump To Lead Broad Asia GainsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
02/09/201313:07Dow Jones NewsASIA MARKETS: Hong Kong Stocks Jump To Lead Broad Asia GainsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
02/09/201311:28Dow Jones NewsASIA MARKETS: Asia Stocks Rise After Official China Factory DataUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
 Showing the most relevant articles for your search:USOTC:DSNKY

Your Recent History

USOTC
ENOGY
Energean (PK)
LSE
GEO
Georgian Mining
BIT
P1YKP8
NLBNPIT1YKP8 20991231 30...
COIN
TBTGBP
TripBit
LSE
0MYM
Vipo As
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved